Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

Recently reported positive preliminary data from Phase 1 dose escalation trial of micvotabart pelidotin (“MICVO,” formerly PYX-201), including ...

Across several states, farmers and ranchers are struggling to find large-animal veterinarians -- the professionals who care ...

Recursion Pharmaceuticals appointed former FDA principal deputy commissioner Namandjé Bumpus, PhD, and Elaine Sun, the COO and CFO of Mammoth Biosciences, to its board of directors. CAMP4 Therapeutics ...

The stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous ...

Merck is also giving Intrexon $25 million in cash to help get the CAR-T programmes going, and says the handover will allow it to focus on its other R&D activities but still maintain an interest in ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a ... Moderna has been accelerating development of its R&D pipeline, which along with follow-up COVID-19 shots ...

On May 13, the INNOVATE100 leaders from across the state will be honored and celebrated in New Brunswick. These professionals ...

The company stated that although it has dropped vobra duo, it remains optimistic about its other candidate MGC026.

Neomycin is an antibiotic that interferes with bacterial protein synthesis by binding primarily to the 30S subunit of bacterial ribosomes. Many vaccines contain trace amounts of neomycin to ...

I disagree with the editorial board’s characterization of Mahmoud Khalil as “a supporter of Hamas” rather than as a supporter ...